Lietuva -
lietuvių -
SMCA (Valstybinė vaistų kontrolės tarnyba)
pamidronate disodium hospira
hospira uk limited - dinatrio pamidronatas - koncentratas infuziniam tirpalui - 6 mg/ml; 3 mg/ml; 9 mg/ml - pamidronic acid
Lietuva -
lietuvių -
SMCA (Valstybinė vaistų kontrolės tarnyba)
phoxilium
baxter holding b.v. - kalcio chloridas dihidratas/magnio chloridas heksahidratas+natrio chloridas/natrio-vandenilio karbonatas/kalio chloridas/dinatrio fosfatas dihidratas - hemodializės ar hemofiltracijos tirpalas - 3,68 g/2,44 g/1000 ml + 6,44 g/2,92 g/0,314 g/0,225 g/1000 ml - hemofiltrates
Lietuva -
lietuvių -
SMCA (Valstybinė vaistų kontrolės tarnyba)
biphozyl
baxter holding b.v. - magnio chloridas heksahidratas+natrio chloridas/natrio-vandenilio karbonatas/kalio chloridas/dinatrio fosfatas dihidratas - hemodializės ar hemofiltracijos tirpalas - 3,05 g/l + 7,01 g/2,12 g/0,314 g/0,187 g/l - hemofiltrates
Lietuva -
lietuvių -
SMCA (Valstybinė vaistų kontrolės tarnyba)
metronidazole vioser
vioser s.a. parenteral solutions industry - metronidazolas - infuzinis tirpalas - 500 mg/100 ml - metronidazole
Europos Sąjunga -
lietuvių -
EMA (European Medicines Agency)
pemetrexed pfizer (previously pemetrexed hospira)
pfizer europe ma eeig - pemetrexed disodium, pemetrexed disodium hemipentahydrate - carcinoma, non-small-cell lung; mesothelioma - antinavikiniai vaistai - malignant pleural mesotheliomapemetrexed pfizer in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed pfizer in combination with cisplatin is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed pfizer is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. pemetrexed pfizer is indicated as monotherapy for the second-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.